Biogen Inc
Simbol: 0R1B.L
LSE
220.98
USDTržna cena danes
27.5773
Razmerje P/E
0.4723
Razmerje PEG
32.12B
Kapaciteta MRK
- 0.00%
Donos DIV
Biogen Inc (0R1B-L) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1049.9 | 4892.8 | 3802.5 | ||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 1473.5 | 1541.1 | ||||||||||||
balance-sheet.row.net-receivables | 0 | 2100 | 2136.4 | 1961.7 | ||||||||||||
balance-sheet.row.inventory | 0 | 2527.4 | 1344.4 | 1351.5 | ||||||||||||
balance-sheet.row.other-current-assets | 0 | 1182 | 1417.6 | 740.8 | ||||||||||||
balance-sheet.row.total-current-assets | 0 | 6859.3 | 9791.2 | 7856.5 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 3729.7 | 3702.5 | 3791.8 | ||||||||||||
balance-sheet.row.goodwill | 0 | 6219.2 | 5749 | 5761.1 | ||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 1850.1 | 2221.3 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 6219.2 | 7599.1 | 7982.4 | ||||||||||||
balance-sheet.row.long-term-investments | 0 | 460.7 | 1957.1 | 2602.2 | ||||||||||||
balance-sheet.row.tax-assets | 0 | 928.6 | 1226.4 | 1415.1 | ||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 8647.3 | 277.8 | 229.3 | ||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 19985.5 | 14762.9 | 16020.8 | ||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 0 | 26844.8 | 24554.1 | 23877.3 | ||||||||||||
balance-sheet.row.account-payables | 0 | 403.3 | 491.5 | 589.2 | ||||||||||||
balance-sheet.row.short-term-debt | 0 | 240.3 | 97.2 | 1088.2 | ||||||||||||
balance-sheet.row.tax-payables | 0 | 257.4 | 259.9 | 174.7 | ||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 6788.2 | 6281 | 6274 | ||||||||||||
Deferred Revenue Non Current | 0 | 400 | 333 | 330.4 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 0 | 2533.3 | 2424.2 | 2446.1 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 8611.1 | 7892.9 | 8619.4 | ||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 400 | 333 | 330.4 | ||||||||||||
balance-sheet.row.total-liab | 0 | 12045.4 | 11165.7 | 12917.6 | ||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | ||||||||||||
balance-sheet.row.retained-earnings | 0 | 17627.6 | 16466.5 | 13911.7 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -153.7 | -164.9 | -106.7 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -2674.6 | -2903.8 | -2908.9 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 14799.4 | 13397.9 | 10896.2 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 26844.8 | 24554.1 | 23877.3 | ||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | -9.5 | 63.5 | ||||||||||||
balance-sheet.row.total-equity | 0 | 14799.4 | 13388.4 | 10959.7 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||
Total Investments | 0 | 460.7 | 3430.6 | 4143.3 | ||||||||||||
balance-sheet.row.total-debt | 0 | 7428.5 | 6711.2 | 7692.6 | ||||||||||||
balance-sheet.row.net-debt | 0 | 6378.6 | 3291.9 | 5431.2 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 1161.1 | 3046.9 | 1556.1 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 494.8 | 518.7 | 487.3 | ||||||||||||
cash-flows.row.deferred-income-tax | 0 | -305.8 | -168.6 | -426.8 | ||||||||||||
cash-flows.row.stock-based-compensation | 0 | -1063.8 | 264.3 | 250.8 | ||||||||||||
cash-flows.row.change-in-working-capital | 0 | -648.7 | -890.3 | -145.5 | ||||||||||||
cash-flows.row.account-receivables | 0 | 56.7 | -222.4 | 326 | ||||||||||||
cash-flows.row.inventory | 0 | -130.9 | -320.2 | -462.4 | ||||||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.other-working-capital | 0 | -574.5 | -347.7 | -9.1 | ||||||||||||
cash-flows.row.other-non-cash-items | 0 | 1909.6 | -1386.7 | 1918 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -7237.5 | -243.2 | -294.9 | ||||||||||||
cash-flows.row.acquisitions-net | 0 | 12.3 | 595 | 28.1 | ||||||||||||
cash-flows.row.purchases-of-investments | 0 | -5140.7 | -3448.5 | -3808.7 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 8288.5 | 4661.3 | 3498.9 | ||||||||||||
cash-flows.row.other-investing-activites | 0 | -11.3 | 24.4 | 12.9 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -4088.7 | 1589 | -563.7 | ||||||||||||
cash-flows.row.debt-repayment | 0 | -187.3 | -1002.2 | -170 | ||||||||||||
cash-flows.row.common-stock-issued | 0 | -44.3 | -1.9 | -0.7 | ||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -750 | -1800 | ||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.other-financing-activites | 0 | -6 | -5.6 | -115.5 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 137 | -1759.7 | -2086.2 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 35.1 | -55.7 | -59.8 | ||||||||||||
cash-flows.row.net-change-in-cash | 0 | -2369.4 | 1157.9 | 930.2 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 1049.9 | 3419.3 | 2261.4 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 3419.3 | 2261.4 | 1331.2 | ||||||||||||
cash-flows.row.operating-cash-flow | 0 | 1547.2 | 1384.3 | 3639.9 | ||||||||||||
cash-flows.row.capital-expenditure | 0 | -7237.5 | -243.2 | -294.9 | ||||||||||||
cash-flows.row.free-cash-flow | 0 | -5690.3 | 1141.1 | 3345 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 9417 | 9433.4 | 10402.4 | ||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 3028.2 | 2797 | 2597 | ||||||||||||
income-statement-row.row.gross-profit | 0 | 6388.8 | 6636.4 | 7805.4 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.operating-expenses | 0 | 4757.5 | 4362.3 | 4940.2 | ||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 7785.7 | 7159.3 | 7537.2 | ||||||||||||
income-statement-row.row.interest-income | 0 | 276.5 | 89.3 | 11 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 268.6 | 263.7 | 289.9 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -334.5 | 1317.7 | -1120 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -334.5 | 1317.7 | -1120 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 268.6 | 263.7 | 289.9 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 494.8 | 518.7 | 487.3 | ||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | 0 | 1631.3 | 2274.1 | 2865.2 | ||||||||||||
income-statement-row.row.income-before-tax | 0 | 1296.8 | 3591.8 | 1745.2 | ||||||||||||
income-statement-row.row.income-tax-expense | 0 | 135.3 | 632.8 | 52.5 | ||||||||||||
income-statement-row.row.net-income | 0 | 1161.1 | 3046.9 | 1556.1 |
Pogosto zastavljeno vprašanje
Kaj je Biogen Inc (0R1B.L) skupna sredstva?
Biogen Inc (0R1B.L) skupna sredstva so 26844800000.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so N/A.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.678.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je -39.271.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je 0.123.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so 0.173.
Kaj je Biogen Inc (0R1B.L) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je 1161100000.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 7428500000.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 4757500000.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 0.000.